| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.74.1.320-325.2000 |
| P8608 | Fatcat ID | release_olxbbbqrjfgy7fc6xmwsesllau |
| P932 | PMC publication ID | 111542 |
| P698 | PubMed publication ID | 10590120 |
| P5875 | ResearchGate publication ID | 12711468 |
| P50 | author | Ollivier Milhavet | Q73235048 |
| David A Harris | Q39486896 | ||
| P2093 | author name string | N Nishida | |
| D Casanova | |||
| J Grassi | |||
| S Lehmann | |||
| D Vilette | |||
| H Laude | |||
| Y Frobert | |||
| P2860 | cites work | Strain-dependent differences in beta-sheet conformations of abnormal prion protein | Q45282297 |
| Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters | Q45968309 | ||
| Demonstration of scrapie strain diversity in infected PC12 cells | Q46665678 | ||
| Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent | Q47616751 | ||
| Biochemical typing of scrapie strains | Q47622354 | ||
| PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology | Q47649749 | ||
| Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. | Q48308927 | ||
| Analysis of the incubation periods, induction of obesity and histopathological changes in senescence-prone and senescence-resistant mice infected with various scrapie strains | Q48348442 | ||
| Normal host prion protein necessary for scrapie-induced neurotoxicity | Q49160879 | ||
| Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. | Q52226096 | ||
| Human prion diseases | Q59690468 | ||
| Screening of monoclonal antibodies using antigens labeled with acetylcholinesterase: application to the peripheral proteins of photosystem 1 | Q68136546 | ||
| The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive | Q68318139 | ||
| Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment | Q72568587 | ||
| Prion Protein Biology | Q21972822 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Mice devoid of PrP are resistant to scrapie | Q28249108 | ||
| Novel proteinaceous infectious particles cause scrapie | Q29547678 | ||
| Eight prion strains have PrP(Sc) molecules with different conformations | Q29617277 | ||
| Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein | Q34294957 | ||
| Molecular biology of prion diseases | Q34534878 | ||
| Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice | Q35523444 | ||
| Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein | Q35764516 | ||
| Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent | Q35851885 | ||
| A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. | Q35899061 | ||
| Doxycycline control of prion protein transgene expression modulates prion disease in mice | Q36527236 | ||
| Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected] | Q36631246 | ||
| Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells | Q36780119 | ||
| Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins | Q36866642 | ||
| Scrapie strain variation and its implications | Q37040427 | ||
| Synthesis and trafficking of prion proteins in cultured cells | Q37373585 | ||
| Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. | Q38287981 | ||
| A Mutant Prion Protein Displays an Aberrant Membrane Association When Expressed in Cultured Cells | Q38290309 | ||
| Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. | Q41478508 | ||
| Foreign PrP expression and scrapie infection in tissue culture cell lines | Q41584786 | ||
| Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis | Q41729068 | ||
| Selective neuronal targeting in prion disease | Q42670555 | ||
| Characterization of scrapie infection in mouse neuroblastoma cells | Q44079577 | ||
| Creutzfeldt-Jakob disease via dural and corneal transplants | Q44494777 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuroblastoma | Q938205 |
| overexpression | Q61643320 | ||
| prion protein family | Q24724413 | ||
| P304 | page(s) | 320-325 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein | |
| P478 | volume | 74 |
| Q58705842 | A Bioluminescent Cell Assay to Quantify Prion Protein Dimerization |
| Q36503630 | A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases. |
| Q34856581 | A bovine cell line that can be infected by natural sheep scrapie prions |
| Q37547427 | A cell-biased effect of estrogen in prion infection. |
| Q92861262 | A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques |
| Q36161465 | A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions |
| Q37252741 | A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner |
| Q40558005 | Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro |
| Q93005212 | All the Same? The Secret Life of Prion Strains within Their Target Cells |
| Q33801179 | Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. |
| Q39719132 | Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. |
| Q27675235 | Anti-prion activity of an RNA aptamer and its structural basis |
| Q28485325 | Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc) |
| Q34580839 | Assessing proteinase K resistance of fish prion proteins in a scrapie-infected mouse neuroblastoma cell line |
| Q48678805 | BSE infection of the small short-lived primate Microcebus murinus |
| Q38936788 | Bioassays and Inactivation of Prions |
| Q40423210 | Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures |
| Q38734782 | Caprine PrP variants harboring Asp-146, His-154 and Gln-211 alleles display reduced convertibility upon interaction with pathogenic murine prion protein in scrapie infected cells |
| Q40071064 | Cell Culture Methods for Screening of Prion Therapeutics. |
| Q43894109 | Cell culture models of transmissible spongiform encephalopathies |
| Q36719055 | Cell-specific susceptibility to prion strains is a property of the intact cell |
| Q37520006 | Cells and prions: a license to replicate |
| Q24677041 | Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles |
| Q27014940 | Cellular aspects of prion replication in vitro |
| Q34171325 | Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain |
| Q34307103 | Characterizing antiprion compounds based on their binding properties to prion proteins: implications as medical chaperones |
| Q33248701 | Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. |
| Q34147720 | Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice. |
| Q40093984 | Cyclodextrins inhibit replication of scrapie prion protein in cell culture. |
| Q39277231 | Cytochalasin D enhances the accumulation of a protease-resistant form of prion protein in ScN2a cells: involvement of PI3 kinase/Akt signalling pathway |
| Q44448848 | Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration |
| Q46106411 | Detection of prion protein oligomers by single molecule fluorescence imaging. |
| Q36354421 | Diagnostic approaches for viruses and prions in stem cell banks |
| Q64989914 | Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrPSc. |
| Q38866973 | Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway |
| Q24682427 | Evaluation of quinacrine treatment for prion diseases |
| Q35053001 | Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein |
| Q40854367 | Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains |
| Q50878634 | FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice |
| Q40734071 | Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release |
| Q38693596 | Generation of Infectious Prions and Detection with the Prion-Infected Cell Assay |
| Q35554422 | Generation of a persistently infected MDBK cell line with natural bovine spongiform encephalopathy (BSE). |
| Q40474826 | Glycosylation-related gene expression in prion diseases: PrPSc accumulation in scrapie infected GT1 cells depends on beta-1,4-linked GalNAc-4-SO4 hyposulfation. |
| Q21131569 | Glypican-1 mediates both prion protein lipid raft association and disease isoform formation |
| Q24670553 | Hot spots in prion protein for pathogenic conversion |
| Q37415409 | Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes |
| Q35122360 | In vitro conversion of normal prion protein into pathologic isoforms |
| Q38544726 | Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein |
| Q42832124 | Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection |
| Q34012527 | Induction of distinct [URE3] yeast prion strains |
| Q33648916 | Infection of cell lines with experimental and natural ovine scrapie agents |
| Q37288844 | Infectious prions accumulate to high levels in non proliferative C2C12 myotubes. |
| Q36436176 | Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives. |
| Q39692874 | Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations. |
| Q34301796 | Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease |
| Q40413509 | Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission |
| Q44544140 | Isolation of drugs active against mammalian prions using a yeast-based screening assay |
| Q30570683 | Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs |
| Q54971223 | Low doses of bioherbicide favour prion aggregation and propagation in vivo. |
| Q37329528 | Measuring prions by bioluminescence imaging |
| Q38721811 | Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells |
| Q35635237 | Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains |
| Q38089150 | Modelling neurodegeneration in prion disease - applications for drug development |
| Q34434726 | Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res |
| Q48219838 | Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection |
| Q44737239 | Neurons and astrocytes respond to prion infection by inducing microglia recruitment. |
| Q34542872 | New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives |
| Q31156724 | New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products |
| Q55044531 | Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity. |
| Q39455005 | Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity |
| Q42559957 | Optimization of Arylamides as Novel, Potent and Brain-penetrant Antiprion Lead Compounds |
| Q40495541 | Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment |
| Q38968003 | Persistent prion infection disturbs the function of Oct-1, resulting in the down-regulation of murine interferon regulatory factor-3 |
| Q90735808 | Poly-L-histidine inhibits prion propagation in a prion-infected cell line |
| Q39682667 | PrP expression and replication by Schwann cells: implications in prion spreading |
| Q43843183 | PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification |
| Q48857869 | Primary culture of neural precursors from the ovine central nervous system (CNS). |
| Q47232273 | Prion Strains and Transmission Barrier Phenomena |
| Q38316783 | Prion degradation pathways: Potential for therapeutic intervention |
| Q35581657 | Prion infection impairs the cellular response to oxidative stress |
| Q34944193 | Prion infection of mouse neurospheres |
| Q36693359 | Prion strain discrimination in cell culture: the cell panel assay |
| Q35023923 | Prion strain-dependent differences in conversion of mutant prion proteins in cell culture |
| Q50126152 | Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis |
| Q28209345 | Prion-like protein Doppel expression is not modified in scrapie-infected cells and in the brains of patients with Creutzfeldt-Jakob disease |
| Q38166717 | Prions Ex Vivo: What Cell Culture Models Tell Us about Infectious Proteins |
| Q37484906 | Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death |
| Q35676678 | Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells. |
| Q35512142 | Prions on the move |
| Q36645420 | Prions: protein only or something more? Overview of potential prion cofactors |
| Q36040834 | Progress in prion vaccines and immunotherapies |
| Q34299382 | Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain |
| Q39387817 | Protective role of interferon regulatory factor 3-mediated signaling against prion infection. |
| Q35714147 | Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells |
| Q42409538 | Quantitative phosphoproteomic analysis of prion-infected neuronal cells |
| Q35745657 | Reaction of complement factors varies with prion strains in vitro and in vivo |
| Q37221670 | Recombinant human prion protein inhibits prion propagation in vitro |
| Q39831418 | Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein |
| Q40139360 | Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins |
| Q33930771 | Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody |
| Q34080020 | Scrapie strains maintain biological phenotypes on propagation in a cell line in culture |
| Q36626116 | Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies |
| Q44090721 | Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells |
| Q35774144 | Strain-Dependent Effect of Macroautophagy on Abnormally Folded Prion Protein Degradation in Infected Neuronal Cells |
| Q28831416 | Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation |
| Q36147951 | Susceptibility of GT1-7 cells to mouse-passaged field scrapie isolates with a long incubation |
| Q37375815 | Susceptibility of cell substrates to PrPSc infection and safety control measures related to biological and biotherapeutical products |
| Q42261396 | Synthesis of an (11) C-labeled antiprion GN8 derivative and evaluation of its brain uptake by positron emission tomography. |
| Q38213991 | The potential of mesenchymal stem cell in prion research. |
| Q39437151 | The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis |
| Q38324712 | The standard scrapie cell assay: development, utility and prospects |
| Q28288758 | The state of the prion |
| Q39652731 | Transcytosis of murine-adapted bovine spongiform encephalopathy agents in an in vitro bovine M cell model. |
| Q40739845 | Transfer of scrapie prion infectivity by cell contact in culture |
| Q33754930 | Transmission barriers for bovine, ovine, and human prions in transgenic mice |
| Q30597888 | Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures |
| Q30981661 | Two expression vectors for the phage-displayed chicken monoclonal antibody |
| Q64284872 | Type I interferon protects neurons from prions in in vivo models |
| Q35710420 | Ubiquitin-specific protease 14 modulates degradation of cellular prion protein |
| Q30373361 | Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity. |
| Q94283405 | generation of tau aggregates conformationally distinct from parent tau seeds of Alzheimer’s brain |
Search more.